JAMP-Clopidogrel recall in Canada: May contain incorrect dose
In plain language
This recall involves JAMP-Clopidogrel tablets sold in Canada. It's being recalled because some tablets may be overweight or underweight, leading to an incorrect dose. Consult your healthcare provider before stopping use and follow the steps in the official notice.
What to do
- Consult your healthcare provider prior to discontinuing use.
- Verify if your product is affected by checking lot numbers.
- Contact JAMP Pharma Corporation if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
JAMP - Clopidogrel 75mg
Lot: EG22CGM002, EG22CGM003, EG23CGM001, EG22CGN001, EG23CGN001, EG23CGN002, EG23CGN003, EG23CGN004, EG23CGL001
Why this matters
Incorrect dose
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: EG22CGM002, EG22CGM003, EG23CGM001, EG22CGN001, EG23CGN001, EG23CGN002, EG23CGN003, EG23CGN004, EG23CGL001
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Incorrect dose
What should consumers do?
Consult your healthcare provider prior to discontinuing use. Verify if your product is affected by checking lot numbers. Contact JAMP Pharma Corporation if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Incorrect dose
When was this product recalled?
This product was recalled on September 6, 2024.
Is the JAMP-Clopidogrel brand affected by this recall?
Yes, JAMP-Clopidogrel products are affected by this recall. This recall involves JAMP-Clopidogrel tablets sold in Canada. It's being recalled because some tablets may be overweight or underweight, leading to an incorrect dose. Consult your healthcare provider before stopping use and follow the steps in the official notice.